Nicolas Rousseau is a graduate from the French Engineering school CentraleSupélec. He has a biomedical engineering master from the University of Cambdrige. After a master thesis projet at the Pasteur Institute on gene therapy, he joined Jeanne Volatron, the CEO of EverZom to build the company. He followed trainings in entrepreneurship at the business school HEC and Deeptech Founders. He is the COO of the company.